Serum corticosteroid-binding globulin, cortisol, and nonprotein-bound cortisol levels in patients receiving estrogen for carcinoma of the prostate

Invest Urol. 1973 Nov;11(3):194-7.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adenocarcinoma / blood
  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / physiopathology
  • Adrenal Glands / physiopathology
  • Binding, Competitive
  • Blood Protein Electrophoresis
  • Carbon Isotopes
  • Clinical Trials as Topic
  • Diethylstilbestrol / therapeutic use*
  • Dose-Response Relationship, Drug
  • Humans
  • Hydrocortisone / blood*
  • Hypothalamo-Hypophyseal System
  • Male
  • Metyrapone
  • Pituitary Gland / physiopathology
  • Pituitary-Adrenal System
  • Placebos
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / physiopathology
  • Serum Albumin / analysis
  • Stimulation, Chemical
  • Time Factors
  • Transcortin*
  • Tritium

Substances

  • Carbon Isotopes
  • Placebos
  • Serum Albumin
  • Tritium
  • Diethylstilbestrol
  • Transcortin
  • Hydrocortisone
  • Metyrapone